Newman Michael James has filed 3 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 52204 shares of Indaptus Therapeutics, Inc. ($INDP) on December 22, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 22, 2025 | Indaptus Therapeutics, Inc. | $INDP | Newman Michael James | CSO and Director | A | Common Stock | 52204 | $2.03 | 101,074.0000 | 1,641,920 | 106.82% | 3.18% |
| Oct. 9, 2024 | Indaptus Therapeutics, Inc. | $INDP | Newman Michael James | CSO and Director | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 8,401,047 | 9999.99% | 0.89% |
| Jan. 22, 2024 | Indaptus Therapeutics, Inc. | $INDP | Newman Michael James | CSO and Director | A | Stock Option (Right to Buy) | 43250 | $0.00 | 43,250.0000 | 8,401,047 | 9999.99% | 0.51% |